Source: Contract Pharma

Fujifilm Diosynth: Fujifilm Diosynth Biotechnologies Completes Facility Expansion in CA

Upgrades its development labs and adds two new independent cell therapy production suites, significantly increasing cleanroom capacity for new client programs.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
Lars Petersen's photo - President & CEO of Fujifilm Diosynth

President & CEO

Lars Petersen

CEO Approval Rating

83/100

Read more